Mitsui ChemicalsMitsui Chemicals, Inc.4183東証プライム化学FY ending Mar 2026, consolidated, IFRS

Mitsui Chemicals revenue and profit

Out of every ¥100 of sales, about ¥4 is left as operating profit. Revenue changed -7.8% from the prior year, operating profit -5.8%.

Five-year trend

Revenue¥1.67T
FY ending Mar 2022: ¥1.61T¥1.61TFY ending Mar 2023: ¥1.88T¥1.88TFY ending Mar 2024: ¥1.75T¥1.75TFY ending Mar 2025: ¥1.81T¥1.81TFY ending Mar 2026: ¥1.67T¥1.67TFY22FY23FY24FY25FY26
Operating income¥73.8B
FY ending Mar 2022: ¥147.3B¥147.3BFY ending Mar 2023: ¥129B¥129BFY ending Mar 2024: ¥74.1B¥74.1BFY ending Mar 2025: ¥78.3B¥78.3BFY ending Mar 2026: ¥73.8B¥73.8BFY22FY23FY24FY25FY26
Operating margin4.4%
FY ending Mar 2022: 9.1%9.1%FY ending Mar 2023: 6.9%6.9%FY ending Mar 2024: 4.2%4.2%FY ending Mar 2025: 4.3%4.3%FY ending Mar 2026: 4.4%4.4%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin2.1%
Asset turnover0.78×
ROA1.6%
ROA1.6%
Financial leverage2.51×
ROE4.0%

Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.

Net margin2.1%
2022: 6.8%6.8%2023: 4.4%4.4%2024: 2.9%2.9%2025: 1.8%1.8%2026: 2.1%2.1%2223242526
Asset turnover0.78×
2022: 0.83×0.83×2023: 0.94×0.94×2024: 0.82×0.82×2025: 0.83×0.83×2026: 0.78×0.78×2223242526
ROA1.6%
2022: 5.7%5.7%2023: 4.1%4.1%2024: 2.3%2.3%2025: 1.5%1.5%2026: 1.6%1.6%2223242526
Financial leverage2.51×
2022: 2.72×2.72×2023: 2.67×2.67×2024: 2.60×2.60×2025: 2.55×2.55×2026: 2.51×2.51×2223242526
ROE4.0%
2022: 15.4%15.4%2023: 11.1%11.1%2024: 6.1%6.1%2025: 3.8%3.8%2026: 4.0%4.0%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
20226.8%0.83×5.7%2.72×15.4%
20234.4%0.94×4.1%2.67×11.1%
20242.9%0.82×2.3%2.60×6.1%
20251.8%0.83×1.5%2.55×3.8%
20262.1%0.78×1.6%2.51×4.0%

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue40.3%
2021: 37.6%37.6%2022: 31.9%31.9%2023: 29.4%29.4%2024: 34.6%34.6%2025: 34.4%34.4%2026: 40.3%40.3%212223242526
PPE ÷ total assets31.3%
2021: 29.2%29.2%2022: 26.6%26.6%2023: 26.8%26.8%2024: 27.3%27.3%2025: 28.9%28.9%2026: 31.3%31.3%212223242526
Goodwill ÷ parent equity2.9%
2021: 0.2%0.2%2022: 2.5%2.5%2023: 2.5%2.5%2024: 2.5%2.5%2025: 2.5%2.5%2026: 2.9%2.9%212223242526
Goodwill balance¥24.8B
2021: ¥1.12B¥1.12B2022: ¥18B¥18B2023: ¥19.3B¥19.3B2024: ¥21.2B¥21.2B2025: ¥21.1B¥21.1B2026: ¥24.8B¥24.8B212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥46.4B
2021: ¥33.8B¥33.8B2022: ¥38.1B¥38.1B2023: ¥43B¥43B2024: ¥44.7B¥44.7B2025: ¥45.8B¥45.8B2026: ¥46.4B¥46.4B212223242526
R&D / revenue2.8%
2021: 2.8%2.8%2022: 2.4%2.4%2023: 2.3%2.3%2024: 2.6%2.6%2025: 2.5%2.5%2026: 2.8%2.8%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue1,612,6881,879,5471,749,7431,809,1641,668,754
Cost of revenue1,233,9481,498,0541,378,9461,420,8721,288,244
Gross profit378,740381,493370,797388,292380,510
SG&A239,356284,589282,657295,352294,540
Operating income147,310128,99874,12478,33673,809
Pretax income141,274117,27873,33171,64768,608
Income tax22,72327,14019,55629,01821,698
Net income attributable to owners109,99082,93649,99932,24234,378
Operating margin9.1%6.9%4.2%4.3%4.4%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 9%
Property, plant and equipment 31%
1%
Other assets 59%

Funding

Other liabilities 54%
Equity 46%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥181.2B¥186.3B¥210.3B¥170.6B¥183.1B
Total assets¥1.93T¥2.07T¥2.22T¥2.15T¥2.15T
Net assets¥807.1B¥883.3B¥984.8B¥970.6B¥988.8B
Share capital¥125.4B¥125.6B¥125.7B¥125.7B¥125.7B
Property, plant and equipment¥514B¥553.3B¥605.8B¥623.1B¥672.7B
Goodwill¥18B¥19.3B¥21.2B¥21.1B¥24.8B
Current assets¥1.03T¥1.09T¥1.15T¥1.04T¥993.2B
Total liabilities¥1.13T¥1.18T¥1.23T¥1.18T¥1.16T
Equity attributable to owners of parent¥712.7B¥786.8B¥862.9B¥848.3B¥864.7B
Retained earnings¥516.1B¥575.1B¥617.4B¥618.3B¥626.6B
Treasury stock-¥34.9B-¥32.7B-¥32.8B-¥42.7B-¥57B

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第29期(2025/04/01-2026/03/31)

    ID S100YGUI2026-06-22Open
  • EDINET (FSA Japan)

    有価証券報告書-第28期(2024/04/01-2025/03/31)

    ID S100W2O42025-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第27期(2023/04/01-2024/03/31)

    ID S100TSNO2024-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第26期(2022/04/01-2023/03/31)

    ID S100R6GQ2023-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第25期(令和3年4月1日-令和4年3月31日)

    ID S100OFZ72022-06-24Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第24期(令和2年4月1日-令和3年3月31日)

    ID S100M0VI2021-07-19Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.